Seaport Therapeutics, Inc. Common Stock (SPTX) — Long-term Investment Intensity

Latest as of March 2026: 13.2%

Seaport Therapeutics, Inc. Common Stock (SPTX) has a Long-term Investment Intensity of 13.2% as of March 2026. Long-term investments of $30.04 Million represent 13.2% of total assets of $227.67 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check SPTX asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

13.2%
LT Investments / Total Assets

Long-term Investments

$30.04 Million
USD

Total Assets

$227.67 Million
USD

Country

USA
NASDAQ

Seaport Therapeutics, Inc. Common Stock Long-term Investment Intensity (2025–2025)

This chart shows how Seaport Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of March 2026, the intensity stands at 13.2%, reflecting long-term investments of $30.04 Million against total assets of $227.67 Million USD. For the complete balance sheet picture, see SPTX asset base.

Annual Long-term Investment Intensity for Seaport Therapeutics, Inc. Common Stock (2025–2025)

The table below presents the year-by-year Long-term Investment Intensity for Seaport Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Seaport Therapeutics, Inc. Common Stock (SPTX) total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 7.1% $17.67 Million $249.01 Million
pp = percentage points